ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163062 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163062; 2) Community: the network communities that were significantly associated with the response to NSC 163062; 3) Molecule: the relationships between components within communities and NSC 163062; 4) MDR: the compounds that were significantly associated with the NSC 163062.

NSC Compound Enrichment Correlation
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00803384002766641 0.045429161
NSC 339137 PHYSALOLACTONE 0.00803384002766641 0.32647427
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.00803384002766641 0.21780682
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00803384002766641 0.19062384
NSC 42972 Null 0.00803384002766641 0.31512386
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.00803384002766641 0.27549984
NSC 624657 ANTINEOPLASTIC-624657 0.00803384002766641 -0.029145398
NSC 633514 Null 0.00803384002766641 0.20323984
NSC 640735 3-(4-Methoxy-2-methylphenyl)naphthol [2,1-c]furan-1(3H)-one 0.00803384002766641 0.18023609
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.00803384002766641 0.18127199
Total:156  Current:51    [First] [Prev] [Next] [Last]